LabCorp in the midst of CEO shuffle

By staff writers

October 7, 2019 -- LabCorp is undergoing top-level executive changes in its business segments, with the appointment of John Ratliff as CEO of LabCorp Diagnostics and Dr. Paul Kirchgraber as CEO of Covance.

The appointments are effective November 1, when Adam Schechter steps up to the role of president and CEO of parent company LabCorp. LabCorp had announced in June that David King was retiring from his position as president and CEO and that Schechter was appointed to the role; at the time, Schechter was president of global human health at Merck.

Dr. Paul Kirchgraber and John Ratliff
Dr. Paul Kirchgraber (left) and John Ratliff (right).

Ratliff has been the CEO of Covance since October 2016. Kirchgraber, who is now the head of clinical trial testing solutions at Covance, is a board-certified pathologist and also holds a master's degree in business administration.

LabCorp also announced that Judi Seltz has been appointed as chief human resources officer, effective October 15. Seltz is currently the chief of human resources at cleaning and hygiene products company Diversey. She was previously senior vice president of global human health at Merck.

Sysmex, LabCorp extend hematology automation pact
Sysmex America and LabCorp announced they are extending their hematology automation agreement. Sysmex America is providing LabCorp Diagnostics' primary...
LabCorp builds on consumer tests
LabCorp is now offering consumers the ability to buy tests online, get tested by a phlebotomist at a convenient location, and receive results through...
With LabCorp's lead, Mount Sinai dives into digital pathology
LabCorp is working with the Mount Sinai healthcare system in New York City to build out digital pathology services, including the establishment of a center...
LabCorp launches Qiagen's FGFR test for bladder cancer
LabCorp announced on May 10 that it has begun offering Qiagen's therascreen companion diagnostic for detecting FGFR mutations in bladder cancer.

Copyright © 2019

Last Updated np 10/7/2019 9:37:22 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.